Navigation Links
ElutraSep Inc. Announces the Launch of the Cryptonite™ HV Filter Module for Cryptosporidium and Giardia Testing
Date:5/15/2009

ElutraSep, Inc. today announced the commercial launch of the Cryptonite™ HV Filter Module for Cryptosporidium and Giardia testing. www.elutrasep.com/app-Cryptosporidium.asp.

Atlanta, GA (PRWEB) May 15, 2009 -- ElutraSep, Inc. today announced the commercial launch of the Cryptonite™ HV Filter Module for Cryptosporidium and Giardia testing. www.elutrasep.com/app-Cryptosporidium.asp

Cryptonite™ HV is a hollow fiber filtration module designed to capture and concentrate Cryptosporidium and Giardia from non-filtered source and finished water samples. Cryptonite™ HV recently underwent method development for method 1623 at an internationally recognized EPA approved laboratory located in Saint Albans, Vermont.

Testing of the new Cryptonite™ HV filter exceeded the recovery requirements set forth for EPA method 1623 and will now allow laboratories an additional choice for sample concentration. Cryptonite™ offers advantages including a recovery procedure with a total elution volume of less than 50 milliliters, no specialized elution equipment or post filtration required and a start to finish process that can be completed in about two minutes.

"We were always aware of the potential benefits that our technology could bring to the EPA 1623 method but lacked a high volume design that could accommodate turbid source waters. Last year, we began the process of designing a high volume module that would be cost competitive and offer substantial advantages over the competition," said Jason Holt, president and CEO of ElutraSep. " Laboratories will no longer have to conduct tedious elution protocols or have to deal with hundreds of milliliters of elution volumes. Module shakers, wash stations and multiple backwashing steps will be a thing of the past," said Jason. "We believe that the competitive costs of the modules, excellent recoveries and simplified workflows will quickly bring Cryptonite to the front of the pack".

Further information may be obtained by visiting the ElutraSep website www.elutrasep.com or by calling 770-781-5080

ElutraSep, Inc. provides concentration technologies and kits that aid in the detection of microorganisms from liquid samples. Primary product lines utilize inter-capillary capture of organisms via specially designed hollow fiber membranes.

ElutraSep products are typically applied to sample preparation stages of waterborne pathogen assays but are also applied to sterility testing programs in the food, beverage and pharmaceutical industries.

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2419224.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... selected by the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® ... annual Women of Innovation Awards Dinner. , The dinner recognizes women accomplished in ...
(Date:3/23/2017)... 2017  Agriculture technology company Cool Planet has closed ... conversion to commercialize its Cool Terra and Cool Fauna ... products that are simultaneously profitable as well as sustainable ... 18 months. This latest round of funding was led ... The company,s primary product, Cool Terra, can ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
Breaking Biology Technology:
(Date:3/20/2017)... , March 20, 2017 PMD Healthcare ... personal spirometer and Wellness Management System (WMS), a remote, ... Founded in 2010, PMD Healthcare is a Medical Device, ... a mission dedicated to creating innovative solutions that empower ... With that intent focus, PMD developed the first ever ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
Breaking Biology News(10 mins):